Immediate Impact

52 standout
Sub-graph 1 of 24

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
8 intermediate papers

Works of Shusuke Okamura being referenced

Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study
2014
The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma
2013
and 5 more

Author Peers

Author Last Decade Papers Cites
Shusuke Okamura 543 212 174 199 34 761
Shigeo Shimose 617 207 152 234 62 860
Hong Wang 570 236 156 299 29 820
O Nakashima 492 218 109 285 29 782
Tomotake Shirono 511 161 100 176 49 678
J Kojima 518 159 107 240 33 782
Ya-Hao Zhou 667 246 210 389 41 866
Chao Li 666 266 218 349 45 933
W Y Lui 286 296 109 211 29 879
H Nakamura 500 171 80 214 38 785
Kazuho Imanaka 350 237 76 342 29 887

All Works

Loading papers...

Rankless by CCL
2026